API Synthesis and New molecule
Our company offers a range of services related to API (Active Pharmaceutical Ingredient) selection, technical support, DMF (Drug Master File) filing, tech transfer support, and niche
impurities synthesis consultation. This is a comprehensive set of services that caters to pharmaceutical companies looking to develop and bring new drugs to market.
01
API Selection
-
Providing guidance on choosing the right API based on potential market results.
​
-
Tailoring recommendations for the specific requirements of the US, Europe, and Asia markets.
03
DMF Filing
-
Assisting in the preparation and submission of Drug Master Files.
​
-
Ensuring compliance with regulatory requirements for market approval.
05
Niche Impurities Synthesis Consultation
-
Providing expertise in the synthesis of niche impurities.
​
-
Offering consultation services to address specific challenges related to impurity synthesis.
02
Technical Support for APIs
-
Offering technical assistance throughout the API development process.
​​
-
Ensuring that the synthesis and manufacturing processes meet regulatory standards.
04
Tech Transfer Support
-
Facilitating the transfer of technology for existing APIs.
​
-
Ensuring a seamless transition between development and manufacturing stages.
06
Development
Consultation
-
Offering consultation services for the overall development of APIs.
​
-
Leveraging the expertise of your professionals to guide clients through the development process.
By combining these services, our company appears to offer end-to-end support for pharmaceutical companies, from the initial stages of API selection to the technical intricacies of DMF filing,tech transfer, and specialized impurity synthesis. This holistic approach is likely to appeal to pharmaceutical companies looking for a comprehensive partner in the drug development process.